Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|November 1, 1986
Poor prognosis metastatic gestational trophoblastic disease: experience with moderate dose methotrexate plus folinic acid rescue as initial therapyA H Gerulath, A J Dembo, S Aitken, et al.
The Bone & Joint Journal|March 5, 2014
The spectrum of fractures in the elderlyC M Court-Brown, N D Clement, A D Duckworth, et al.
Frontiers in Nutrition|June 5, 2023
Nutrition, lifestyle, and cognitive performance in esport athletesJenna B Goulart, Logan S Aitken, Saman Siddiqui, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|February 15, 2021
Strategies and considerations for implementing genomic selection to improve traits with additive and non-additive genetic architectures in sugarcane breedingKai P Voss-Fels, Xianming Wei, Elizabeth M Ross, et al.
Plant Biotechnology Journal|April 24, 2009
Targeted single nucleotide polymorphism (SNP) discovery in a highly polyploid plant species using 454 sequencingPeter C Bundock, Frances G Eliott, Gary Ablett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancerL Eapen, D Stewart, C Danjoux, et al.
BMC Genomics|February 26, 2014
A comprehensive genetic map of sugarcane that provides enhanced map coverage and integrates high-throughput Diversity Array Technology (DArT) markersKaren S Aitken, Meredith D McNeil, Scott Hermann, et al.
Scientific Reports|November 17, 2016
Ku70 Serine 155 mediates Aurora B inhibition and activation of the DNA damage responseVictoria L Fell, Elizabeth A Walden, Sarah M Hoffer, et al.
Journal of Experimental Botany|June 21, 2015
Using quantitative PCR with retrotransposon-based insertion polymorphisms as markers in sugarcaneCushla J Metcalfe, Sarah G Oliveira, Jonas W Gaiarsa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: a National Cancer Institute of Canada Clinical Trials Group studyD J Stewart, E A Eisenhauer, J Skillings, et al.
Pageof 8